Related Experiment Video
Updated: Apr 25, 2026

A Novel Method for Involving Women of Color at High Risk for Preterm Birth in Research Priority Setting
Published on: January 12, 2018
Medicaid Expansion and Severe Maternal Morbidity
Emily K Guernsey1, Valeria Hernandez, John Cursio
1Pritzker School of Medicine, the Department of Family Medicine, and the Department of Public Health Sciences, University of Chicago, Chicago, Illinois; and the Division of Maternal-Fetal Medicine, Department of Obstetrics & Gynecology, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina.
Objective:
To evaluate whether there is an association between state-level Medicaid expansion and severe maternal morbidity (SMM) among Medicaid enrollees who delivered between 2010 and 2018.
Methods:
This is a secondary analysis of Medicaid claims that uses national Medicaid analytic files. We included Medicaid enrollees with delivery hospitalizations between 2010 and 2018 in all states that expanded Medicaid under the Affordable Care Act (ACA) by July 2016. The primary outcome was SMM, defined using the Centers for Disease Control and Prevention's validated list of 21 indicators. The primary exposure was whether the enrollee's state of residence had expanded Medicaid 21 months before their delivery under the ACA, to allow for 1 year of expansion before a 9-month pregnancy. We also included analyses that allowed for a 9-month lag after expansion so that Medicaid expansion was in place at the start of a pregnancy. We calculated annual rates of SMM by Medicaid expansion status and analyzed trends across time. We used logistic regression to estimate the association between timing of deliveries relative to Medicaid expansion and SMM at the delivery encounter.
Results:
Data for 6,976,586 individuals were available for analysis in 30 of the 31 states that expanded Medicaid by July 2016. Rates of SMM trended downward after Medicaid expansion in these states. Individuals who delivered at least 21 months after state Medicaid expansions were significantly less likely to experience SMM relative to those who delivered before Medicaid expansion (including blood transfusion: odds ratio [OR] 0.79; 95% CI, 0.68-0.90; excluding blood transfusion: OR 0.76; 95% CI, 0.65-0.88).
Conclusion:
Medicaid expansion was associated with decreased odds of SMM.
More Related Videos
Related Concept Videos
Standards of Care I
Mitral Valve Prolapse III: Nursing Management
Issues And Trends In Healthcare Delivery System
Cost Containment
Payment for healthcare services has historically promoted adoption of costly and often unnecessary or inefficient...
Methods of Documentation VI: Case Management Model
For example, a patient with a chronic...
Mitral Stenosis IV: Nursing Management
Pathophysiology of Diabetes
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...

